Scientists Silenced About the Dangers of Avandia--Attorney Resources
Read on for information about the dangerous side effects of Avandia; get
attorney resources.
On June 6, 2007, the Food and Drug Administration
(FDA) requested that a black box warning be added to Avandia, a drug for those
with Type 2 diabetes. The so-called "black box" is the agency's strictest
warning to the public for drugs. Studies have found that Avandia increases the
risk of heart failure and heart attacks in users.
On June 12, 2007, the
New York Times published an editorial saying GlaxoSmithKline, maker of
Avandia, "failed to vigorously pursue questions about cardiac safety and the
Food and Drug Administration acquiesced in its feeble efforts."
The
editorial goes on to say that both The FDA and Glaxo were guilty of either
ignoring or silencing scientists who raised the alarm about the safety of
Avandia.
An FDA safety officer reportedly told the Times that she
was reprimanded and removed from her duties of assessing the safety of Avandia
after she recommended that it receive a black box warning.
Most alarming,
however, is that Glaxo was alerted as early as 1999 about the potential risks to
taking Avandia. According to the Times, Dr. John Buse, then a junior
academic, warned the drugmaker about the cardiac risks.
If you or a
loved one has suffered cardiac complications after ingesting Avandia, you
deserve the guidance of a knowledgeable drug attorney. Get a free case review by
filling out the form below.
see also:
FDA Warning, 5.22.07
FDA Alert on the Anti-Diabetes Drug Avandia: Risk of Heart AttackRisks to taking the drug Avandia include heart attack and chest pain
Veterans Affairs: Avandia
Veterans Affairs Severely Limits Use of GlaxoSmithKline's Avandia DrugVeterans Affairs Limits Use of Glaxo's Avandia Due to Safety Concerns
News & Warnings
Avandia Breaking News: Glaxo Warned in 2001 about Misleading MarketingBloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001
